Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Sex-independent neuroprotection with minocycline after experimental thromboembolic stroke.
Hoda MN, Li W, Ahmad A, Ogbi S, Zemskova MA, Johnson MH, Ergul A, Hill WD, Hess DC, Sazonova IY.
Exp Transl Stroke Med. 2011 Dec 16;3(1):16.
Related citations
Combination treatment with low-dose Niaspan and tissue plasminogen activator provides neuroprotection after embolic stroke in rats.
Shehadah A, Chen J, Cui Y, Zhang L, Roberts C, Lu M, Chopp M.
J Neurol Sci. 2011 Oct 15;309(1-2):96-101. Epub 2011 Jul 29.
Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke.
Machado LS, Kozak A, Ergul A, Hess DC, Borlongan CV, Fagan SC.
BMC Neurosci. 2006 Jul 17;7:56.
Minocycline and tissue-type plasminogen activator for stroke: assessment of interaction potential.
Machado LS, Sazonova IY, Kozak A, Wiley DC, El-Remessy AB, Ergul A, Hess DC, Waller JL, Fagan SC.
Stroke. 2009 Sep;40(9):3028-33. Epub 2009 Jul 23.
Neuroprotective effects of female gonadal steroids in reproductively senescent female rats.
Alkayed NJ, Murphy SJ, Traystman RJ, Hurn PD, Miller VM.
Stroke. 2000 Jan;31(1):161-8.
Sex differences in minocycline-induced neuroprotection after experimental stroke.
Li J, McCullough LD.
J Cereb Blood Flow Metab. 2009 Apr;29(4):670-4. Epub 2009 Feb 4.
Extension of the thrombolytic time window with minocycline in experimental stroke.
Murata Y, Rosell A, Scannevin RH, Rhodes KJ, Wang X, Lo EH.
Stroke. 2008 Dec;39(12):3372-7. Epub 2008 Oct 16.
Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats.
Xu L, Fagan SC, Waller JL, Edwards D, Borlongan CV, Zheng J, Hill WD, Feuerstein G, Hess DC.
BMC Neurol. 2004 Apr 26;4:7.
Protective effect of high-density lipoprotein-based therapy in a model of embolic stroke.
Lapergue B, Moreno JA, Dang BQ, Coutard M, Delbosc S, Raphaeli G, Auge N, Klein I, Mazighi M, Michel JB, Amarenco P, Meilhac O.
Stroke. 2010 Jul;41(7):1536-42. Epub 2010 Jun 3.
17beta-estradiol reduces stroke injury in estrogen-deficient female animals.
Rusa R, Alkayed NJ, Crain BJ, Traystman RJ, Kimes AS, London ED, Klaus JA, Hurn PD.
Stroke. 1999 Aug;30(8):1665-70.
Estrogen and Bcl-2: gene induction and effect of transgene in experimental stroke.
Alkayed NJ, Goto S, Sugo N, Joh HD, Klaus J, Crain BJ, Bernard O, Traystman RJ, Hurn PD.
J Neurosci. 2001 Oct 1;21(19):7543-50.
Monitoring the protective effects of minocycline treatment with radiolabeled annexin V in an experimental model of focal cerebral ischemia.
Tang XN, Wang Q, Koike MA, Cheng D, Goris ML, Blankenberg FG, Yenari MA.
J Nucl Med. 2007 Nov;48(11):1822-8. Epub 2007 Oct 17.
Experimental stroke and neuroprotection in the aging rat brain.
Davis M, Mendelow AD, Perry RH, Chambers IR, James OF.
Stroke. 1995 Jun;26(6):1072-8.
Usefulness of postischemic thrombolysis with or without neuroprotection in a focal embolic model of cerebral ischemia.
Yang Y, Li Q, Miyashita H, Howlett W, Siddiqui M, Shuaib A.
J Neurosurg. 2000 May;92(5):841-7.
Reduced brain infarct volume and improved neurological outcome by inhibition of the NR2B subunit of NMDA receptors by using CP101,606-27 alone and in combination with rt-PA in a thromboembolic stroke model in rats.
Yang Y, Li Q, Yang T, Hussain M, Shuaib A.
J Neurosurg. 2003 Feb;98(2):397-403.
Ischemic neuroprotection with selective kappa-opioid receptor agonist is gender specific.
Chen CH, Toung TJ, Hurn PD, Koehler RC, Bhardwaj A.
Stroke. 2005 Jul;36(7):1557-61. Epub 2005 Jun 2.
Progesterone is neuroprotective following cerebral ischaemia in reproductively ageing female mice.
Gibson CL, Coomber B, Murphy SP.
Brain. 2011 Jul;134(Pt 7):2125-33.
Postischemic cerebrovascular E-selectin expression mediates tissue injury in murine stroke.
Huang J, Choudhri TF, Winfree CJ, McTaggart RA, Kiss S, Mocco J, Kim LJ, Protopsaltis TS, Zhang Y, Pinsky DJ, Connolly ES Jr.
Stroke. 2000 Dec;31(12):3047-53.
Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window.
Belayev L, Liu Y, Zhao W, Busto R, Ginsberg MD.
Stroke. 2001 Feb;32(2):553-60.
Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors.
Dong W, Li N, Gao D, Zhen H, Zhang X, Li F.
J Vasc Surg. 2008 Sep;48(3):709-14. Epub 2008 Jun 24.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on